Beijing Continent Pharmaceutical Co, Ltd.

Related records

Trials (29)

• [¹⁴C] Hydronidone Mass Balance Study
• A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis
• A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.
• A Study About Safety and Efficacy of Pirfenidone to Treat Grade 2 or Grade3 Radiation-induced Lung Injury.
• A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis
• A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis
• A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal Insufficiency
• Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir Amibufenamide
• Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis
• Efficacy and Safety of Pirfenidone in Patient With Dermatomyositis Interstitial Lung Disease (Dm-ILD)
• Efficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung Disease
• F573 for Injection for the Treatment of Liver Injury/Failure
• F573 Ia Clinical Trial
• Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
• Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.
• Pharmacokinetic Interactions Between Hydronidone and Entecavir Capsules in Healthy Chinese Subjects
• Pirfenidone Capsule in Patients With Chronic Kidney Disease G2 and G3a Study on Safety and Pharmacokinetics
• Pirfenidone Capsules in the Treatment of Radiation-induced Lung Injury With or Without Immune Pneumonia
• Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP
• Pirfenidone Treat Myocardial Fibrosis After Acute Myocardial Infarction